Diagnostic criteria for sporadic Creutzfeldt-Jakob disease

Archives of Neurology

Volumn 53, Issue 9, 1996, Pages 913-920

  Kretzschmar, Hans A ^a   Ironside, James W ^b   DeArmond, Stephen J ^c   Tateishi, Jun ^d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC PROCEDURE; ELECTROENCEPHALOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MICROSCOPY; MYOCLONUS; NEUROPATHOLOGY; PRION; PRIORITY JOURNAL; RELIABILITY;

EID: 0029741936     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550090125018     Document Type: Article

References (51)

1. Prusiner SB, Hsiao KK. Human prion disease. Ann Neurol. 1994;35:385-395.
2. Wells GAH, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy. Vet Rec. 1987;121:419-420.
3. Concerted Action of the EU. Surveillance of Creutzfeldt-Jakob disease in the European community. Minutes of the second meeting in Rome, July 3, 1993 and the third meeting in Paris, April 29-30, 1994.
4. Brown P, Gibbs CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35:513-529.
5. Brown P. EEG findings in Creutzteldt-Jakob disease. JAMA. 1993;269:3168.
6. Cathala F, Baron H. Clinical aspects of Creutzfeldt-Jakob disease. In: Prusiner SB, McKinley MP, eds. Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Orlando, Fla: Academic Press Inc; 1987:467-509.
7. Budka H, Aguzzi A, Brown P, et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5:319-322.
8. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177-188.
9. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilkunde. 1921;70:132-146.
10. Collinge J, Owen F, Poulter M, et al. Prion dementia without characteristic pathology. Lancet. 1990;336:7-9.
11. Hansen LA, Masliah E, Terry RO, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl). 1989;78:194-201.
12. Mizutani T, Okumura A, Oda M, Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol. 1981;44:103-115.
13. Kitamoto T, Shin R-W, Doh-ura K, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol. 1992;140:1285-1294.
14. Hayward PAR, Bell JE, Ironside JW. Prion protein immunocytochemistry: Reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 1994;20:375-383.
15. Kretzschmar MA. Human prion diseases (spongiform encephalopathies). Arch Virol Suppl. 1993;7:261-293.
16. DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB. Changes in the localization of brain prion proteins during scrapie infection. Neurology. 1987;37:1271-1280.
17. Casaccia P, Ladogana A, Xi YG, Pocchiari M. Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie. Arch Virol. 1989;108:145-150.
18. Kitamoto T, Tateishi J. Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol. 1988;131:435-443.
19. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology. 1990;40:887-890.
20. Doi-Yi R, Kitamoto T, Tateishi J. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta Neumpathol (Berl). 1991; 82:260-265.
21. Haritani M, Spencer Yl, Wells GAH. Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain. Acta Neuropathol (Berl). 1994;87:86-90;
22. Kitamoto T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol. 1992;141:271-277.
23. DeArmond SJ, Prusiner MB. Etiology and pathogenesis of prion diseases. Am J Pathol. 1995;146:785-811.
24. Goodbrand IA, Ironside JW, Nicolson D, Bell JE. Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldl-Jakob disease. Neurosci Lett. 1995;183:127-130.
25. Hecker R, Taraboulos A, Scott M, et al. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 1992;6:1213-1228.
26. Taraboulos A, Jendroska K, Serban D, Yang S-L, DeArmond SJ, Prusiner SB. Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A 1992; 89:7620-7624.
27. David-Ferreira JF, David-Ferreira KL, Gibbs CJJ, Morris JA. Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med. 1968; 127:313-320.
28. Liberski PP, Budka H. Tubulovesicular structures in Gerstmann-Sträussler-Scheinker disease. Acta Neuropathol (Berl). 1994;88:491-492.
29. Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol (Berl). 1990;79:349-354.
30. Liberski PP, Budka H, Sluga E, Barcikowska M, Kwiecinski H. Tubulovesicuiar structures in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 1992;84:238-243.
31. Bockman JM, Kingsbury DT, McKinley MP, Bendheim PE, Prusiner SB. Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med. 1985;312:73-78.
32. Brown P, Coker-Vann M, Pomeroy K, et al. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med. 1986;314:547-551.
33. Xi YG, Cardone F, Pocchiari M. Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients. J Neurol Sci. 1994;124:171-173.
34. Brown P. The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev Neurol (Paris). 1992;148:317-327.
35. Doh-ura K, Tateishi J, Kitamoto T. Sasaki H, Sakaki Y, Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant protein common to Gerstmann-StrZussier syndrome. Ann Neurol. 1990;27:121-126.
36. Gibbs CJ Jr, Gajdusek DG, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968;161: 388-389.
37. Prusiner SB. The biology of prion transmission and replication. In: Prusiner SB, McKinley MP, eds. Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Orlando, Fla: Academic Press Inc; 1987;83-112.
38. KitamotoT, Tateishi J, Sawa H, Doh-ura K. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques. Lab Invest. 1989;60:507-512.
39. Tateishi J, Doh-ura K, Kitamoto T, et al. Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. In: Prusiner SB, Collinge J, Powell J, Anderton B, eds. Prion Diseases of Humans and Animals. London, England: Ellis Horwood; 1992:129-138.
40. Muramoto T, Kitamoto T, Tateishi J, Goto I. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Brain Res. 1992;559:309-316.
41. Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A. 1994;91:9936-9940.
42. Merz PA, Somerville RA, Wisniewski HM, Iqbal K, Abnormal fibrils from scrapieinfected brain. Acta Neumpathol (Berl). 1981;54:63-74.
43. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 1983;35:349-358.
44. DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McCulloch JR, Prusiner SB. Identification of prion amyloid filaments in scrapie-infected brain. Cell. 1985; 41:221-235.
45. Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE. Scrapieassociated fibrils in Creutzfeldt-Jakob disease, Nature. 1983;306:474-476.
46. Jimi T, Wakayama Y, Shibuya S, et al. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta. 1992;211:37-46.
47. Wakayama Y, Shibuya S, Kawase J, Sagawa F, Hashizume Y. High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-jakob disease. Klin Wochenschr. 1987;65:798-801.
48. Zerr I, Bodemer M, Räcker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 1995;345: 1609-1610.
49. Harrington MG, Merril CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 1986;315:279-283.
50. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921-925.
51. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol. 1987;61:3688-3693.